Electroceuticals could treat refractory diseases by the selective modulation of peripheral nerves but their utility is hindered by the small sizes and the delicate nature of the nerves. Here, the authors address these issues by developing an injectable, stable, and conductive hydrogel that allows a safer and more effective treatment during chronic neuromodulation of delicate peripheral nerves.
- Ming Yang
- Lufang Wang
- Zhiqiang Luo